68 related articles for article (PubMed ID: 15703839)
1. Phosphorylation of mdm2 at serine 269 impairs its interaction with the retinoblastoma protein.
Götz C; Kartarius S; Schwär G; Montenarh M
Int J Oncol; 2005 Mar; 26(3):801-8. PubMed ID: 15703839
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells.
Hjerrild M; Milne D; Dumaz N; Hay T; Issinger OG; Meek D
Biochem J; 2001 Apr; 355(Pt 2):347-56. PubMed ID: 11284721
[TBL] [Abstract][Full Text] [Related]
3. Identification of a CK2 phosphorylation site in mdm2.
Götz C; Kartarius S; Scholtes P; Nastainczyk W; Montenarh M
Eur J Biochem; 1999 Dec; 266(2):493-501. PubMed ID: 10561590
[TBL] [Abstract][Full Text] [Related]
4. The carboxy terminus of p53 mimics the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylation.
Guerra B; Götz C; Wagner P; Montenarh M; Issinger OG
Oncogene; 1997 Jun; 14(22):2683-8. PubMed ID: 9178766
[TBL] [Abstract][Full Text] [Related]
5. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase CK1delta phosphorylates key sites in the acidic domain of murine double-minute clone 2 protein (MDM2) that regulate p53 turnover.
Winter M; Milne D; Dias S; Kulikov R; Knippschild U; Blattner C; Meek D
Biochemistry; 2004 Dec; 43(51):16356-64. PubMed ID: 15610030
[TBL] [Abstract][Full Text] [Related]
7. A novel site of AKT-mediated phosphorylation in the human MDM2 onco-protein.
Milne D; Kampanis P; Nicol S; Dias S; Campbell DG; Fuller-Pace F; Meek D
FEBS Lett; 2004 Nov; 577(1-2):270-6. PubMed ID: 15527798
[TBL] [Abstract][Full Text] [Related]
8. Interaction between the retinoblastoma protein and the oncoprotein MDM2.
Xiao ZX; Chen J; Levine AJ; Modjtahedi N; Xing J; Sellers WR; Livingston DM
Nature; 1995 Jun; 375(6533):694-8. PubMed ID: 7791904
[TBL] [Abstract][Full Text] [Related]
9. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2.
Allende-Vega N; Dias S; Milne D; Meek D
Mol Cell Biochem; 2005 Jun; 274(1-2):85-90. PubMed ID: 16335531
[TBL] [Abstract][Full Text] [Related]
11. HDM2 phosphorylation by MAPKAP kinase 2.
Weber HO; Ludwig RL; Morrison D; Kotlyarov A; Gaestel M; Vousden KH
Oncogene; 2005 Mar; 24(12):1965-72. PubMed ID: 15688025
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.
Kulikov R; Boehme KA; Blattner C
Mol Cell Biol; 2005 Aug; 25(16):7170-80. PubMed ID: 16055726
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the retinoblastoma-dependent Mdm2 and E2F-1 signaling pathways during neuronal apoptosis.
Trinh E; Boutillier AL; Loeffler JP
Mol Cell Neurosci; 2001 Feb; 17(2):342-53. PubMed ID: 11178871
[TBL] [Abstract][Full Text] [Related]
14. Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase.
Melnikova VO; Santamaria AB; Bolshakov SV; Ananthaswamy HN
Oncogene; 2003 Sep; 22(38):5958-66. PubMed ID: 12955074
[TBL] [Abstract][Full Text] [Related]
15. Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression.
Meng RD; Shih H; Prabhu NS; George DL; el-Deiry WS
Clin Cancer Res; 1998 Jan; 4(1):251-9. PubMed ID: 9516979
[TBL] [Abstract][Full Text] [Related]
16. The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression.
Sterner JM; Tao Y; Kennett SB; Kim HG; Horowitz JM
Cell Growth Differ; 1996 Jan; 7(1):53-64. PubMed ID: 8788033
[TBL] [Abstract][Full Text] [Related]
17. Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1.
Burch LR; Scott M; Pohler E; Meek D; Hupp T
J Mol Biol; 2004 Mar; 337(1):115-28. PubMed ID: 15001356
[TBL] [Abstract][Full Text] [Related]
18. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
[TBL] [Abstract][Full Text] [Related]
19. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53.
Higashitsuji H; Higashitsuji H; Itoh K; Sakurai T; Nagao T; Sumitomo Y; Masuda T; Dawson S; Shimada Y; Mayer RJ; Fujita J
Cancer Cell; 2005 Jul; 8(1):75-87. PubMed ID: 16023600
[TBL] [Abstract][Full Text] [Related]
20. HDM2 negatively affects the Chk2-mediated phosphorylation of p53.
Bjørling-Poulsen M; Meek D; Issinger OG
FEBS Lett; 2005 May; 579(12):2604-8. PubMed ID: 15862297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
